Andersen, Brian M <br/><br/>
Increasing the efficacy of tumor cell vaccines by enhancing cross priming.  [electronic resource] 

 -  Cancer letters  Dec 2012 
 - 155-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2012.07.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, Neoplasm--immunology<br/>Apoptosis<br/>Autophagy<br/>Brain Neoplasms--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--administration & dosage<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Cross-Priming<br/>Dendritic Cells--immunology<br/>Drug Design<br/>Glioma--immunology<br/>Humans<br/>Immunization, Secondary<br/>Immunologic Memory<br/>Immunotherapy, Active<br/>Interferon-alpha--biosynthesis<br/>Interleukin-12--biosynthesis<br/>Ligands<br/>Neoplasms--therapy<br/>Receptors, Immunologic--immunology<br/>Remission Induction<br/>Toll-Like Receptors--immunology<br/>Treatment Outcome